Details

Autor(en) / Beteiligte

• Lee, Sang Hak
• Ko, Young-Guk
• Jang, Yangsoo
• Kwon, Hyuck Moon
• Lee, Seung-Hwan
• Yoon, Jung Han
• Park, Si Hoon
• Kim, Byung Ok
• Jeon, Dong Woon
• Yang, Joo Young
• Ryu, Seung-Ki

Titel

Sirolimus- versus Paclitaxel-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis

Ist Teil von

• Cardiology, 2005-01, Vol.104 (4), p.181-185

Ort / Verlag

Basel, Switzerland: S. Karger AG

Erscheinungsjahr

2005

Quelle

MEDLINE

Beschreibungen/Notizen

• We performed this study in order to compare the immediate and mid-term outcomes of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in lesions of the unprotected left main coronary artery (LMCA). We assessed 54 patients from 5 centers who had undergone unprotected LMCA stenting (35 SES and 19 PES). The procedural success rates were 100 and 95%, respectively, in the SES and PES patients (p = 0.19). At the 6-month clinical follow-up, the event-free probability was 100% in the SES group, and 88% in the PES group (p = 0.07). At the 6-month angiographic follow-up (n = 24), the SES group exhibited a slightly lower late loss than did the PES group (0.24 ± 0.44 vs. 0.65 ± 0.60 mm, p = 0.09), and the restenosis rates were 8 and 9% (p = 0.94) in the SES and PES patients, respectively. In conclusion, both groups exhibited excellent in-hospital and 6-month outcomes with no significant differences between them.